Fri12152017

Last update12:52:49 PM

Back You are here: Home Biology & biomedicine Success stories

Transgenic plants to produce drugs against malaria

A gene of the Artemisia annua plant doubles the production of artemisinin. Artemisinin-based combination therapy (ACT) is the standard treatment for malaria worldwide, endorsed by the World Health Organization (WHO). The discovery represents an important step towards reducing artemisinin production costs.

Read more...

Autonomous sensor for the detection of breathing problems

Scientists from the Microelectronics Institute of Barcelona (IMB CNM – CSIC), the Universitat Autònoma de Barcelona (UAB), and the Universitat Politècnica de Catalunya (UPC) have developed an autonomous thermoelectric sensor based on silicon nanotechnology to detect flow changes. It can be applied to the  detection of breathing problems.

Read more...

A sensor allows monitoring renal lithiasis at home

A robust, precise and low-cost sensor allows accurate and quick analysis of urinary pH testing. Developed at the Instituto de Microelectrónica de Barcelona (IMB-CNM) of the CSIC, it will be implemented within the first easy-to-use device, suitable for use by lithiasic patients at home. This device is being developed by the company Devicare and is based on a patent by the Universitat de les Illes Balears.

Read more...

New nanodrug improves the treatment of diabetic foot ulcers

A nanomedicine developed and patented by the research group Nanomol at the Instituto de Ciencia de Materiales de Barcelona (CSIC), and by the Centro de Ingeniería Genética y Biotecnología in Cuba, will be commercialized by the company Heber Biotec. The agreement will allow the development and commercialization of a nanoformulated protein for the improved treatment of diabetic foot ulcers.

Read more...

ComFuturo, partnership between companies and science

The Spanish National Research Council (CSIC) and the Fundación General CSIC have launched the program ComFuturo, which supposes an alliance between the CSIC and the companies.

Read more...